Mikkel Hansen is the Nordic Medical Director, CMO at Philips as well as Global Pharma Task force Executive. He joined Philips in January 2015. In this role, Mikkel is responsible for clinical research and services across Philips portfolio of solutions. He is also leading business development of medical and clinical services in the Nordics. He focuses on wearables, e-health and connected care in clinical research.
Before joining Philips, he worked 8 years in the pharmaceutical industry, primarily leading a global medical affairs function at LEO Pharma A/S. In this role he was responsible for identifying clinical value and health outcomes, as well as documenting and communicating this value to clinical stakeholders with a global outlook. Through his integration with the R&D organization he contributed to identification of new behavior focused endpoints and assessment tools. He contributed to disease strategy development, project business plans for early development projects, stage-gate governance models for drug development projects as well as drug-device combination development projects. He chaired the development of a framework for strategic publication planning, including health economy outcomes.
In 2005, Mikkel completed his studies at Copenhagen University.